L 751164Alternative Names: Milaforsin; Milaforsin hydrochloride
Latest Information Update: 16 Aug 2002
At a glance
- Originator Merck Sharp & Dohme
- Class Antiplatelets; Cardiotonics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Heart failure
Most Recent Events
- 29 Jan 1998 New profile
- 28 Jan 1998 Preclinical development for Heart failure in USA (IV)